Model Using Routine Clinical Data May Predict Pancreatic Cancer Risk

MONDAY, Feb. 14, 2022 -- A model using routine clinical information can predict pancreatic ductal adenocarcinoma (PDA) following diagnosis of impaired fasting glucose (IFG), according to a study published in the January issue of the European Journal...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news